Callitas Theraputics Inc., a wholly owned subsidiary of Callitas Health Inc.

admin

About admin

This author has not yet filled in any details.
So far admin has created 52 blog entries.

M Pharmaceutical Inc. Receives USPTO Trademark Protection for Extrinsa for the Treatment of Female Sexual Dysfunction

2017-06-30T10:22:33+00:00

Cincinnati, Ohio (June 6, 2017) M Pharmaceutical Inc. (CSE:MQ, OTCQB: MPHMF, FWB:T3F2 ), (the "Company" or “M Pharma”), is pleased to announce that it has recently received official USPTO “Notice Of Allowance” for the US Trademark of EXTRINSA the Company’s solutionfor Female Sexual Dysfunction (FSD). “We are excited to receive this additional USPTO trademark protection [...]

M Pharmaceutical Inc. Receives USPTO Trademark Protection for Extrinsa for the Treatment of Female Sexual Dysfunction 2017-06-30T10:22:33+00:00

M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services To Develop Regulatory Strategy For Recently Patented Extrinsa For the Treatment of Female Sexual Dysfunction

2017-06-30T10:23:32+00:00

Cincinnati, Ohio (June 2, 2017) M Pharmaceutical Inc. (CSE:MQ, OTCQB: MPHMF, FWB:T3F2 ), (the "Company" or “M Pharma”), is pleased to announce that it has engaged  Camargo Pharmaceutical Services, in order to help advance a drug development strategy for the Company’s recently patented Extrinsa product for Female Sexual Dysfunction (FSD). Known for their experience and [...]

M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services To Develop Regulatory Strategy For Recently Patented Extrinsa For the Treatment of Female Sexual Dysfunction 2017-06-30T10:23:32+00:00

M Pharmaceutical Inc. Announces Successful Pre-IND Meeting Results

2017-06-30T10:26:12+00:00

Cincinnati, Ohio (May 31, 2017) M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), a clinical-stage company developing innovative technologies for weight management and female health & wellness, today announced that with the assistance of Camargo Pharmaceutical Services (“Camargo”), it received a successful response from the US Food and Drug [...]

M Pharmaceutical Inc. Announces Successful Pre-IND Meeting Results 2017-06-30T10:26:12+00:00

M Pharmaceutical Inc. Enhances USA Market Profile and Trading with DTC Eligibility Approval on OTC

2017-07-31T08:04:55+00:00

VANCOUVER, B.C., CANADA (April 7, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”) announces today that it has been made eligible for book-entry delivery and depository services of The Depository Trust Company (the "DTC") to facilitate electronic settlement and transfer of its common shares on the US [...]

M Pharmaceutical Inc. Enhances USA Market Profile and Trading with DTC Eligibility Approval on OTC 2017-07-31T08:04:55+00:00

M Pharmaceutical Inc. Appoints Kim Whittemore of San Diego, California to Its Board of Directors

2017-07-31T08:19:48+00:00

VANCOUVER, B.C., CANADA (March 3rd, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”) announces that Kim Whittemore has been appointed to the Company’s Board of Directors. “Kim Whittemore provides M Pharma with extensive knowledge and expertise within the women’s health space, a central focus of our business growth strategy,” [...]

M Pharmaceutical Inc. Appoints Kim Whittemore of San Diego, California to Its Board of Directors 2017-07-31T08:19:48+00:00

M Pharmaceutical Inc. Appoints Mr. William A. Rodgers Jr., of Milton, Georgia to Its Board of Directors

2017-07-31T08:30:31+00:00

VANCOUVER, B.C., CANADA (February 21, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”) President and CEO, Mr. Gary Thompson, announces that Mr. William A. Rodgers Jr., of Milton, Georgia has been appointed to the Company’s board of directors. “As M Pharma continues to expand its product portfolio, advance regulatory [...]

M Pharmaceutical Inc. Appoints Mr. William A. Rodgers Jr., of Milton, Georgia to Its Board of Directors 2017-07-31T08:30:31+00:00

M Pharmaceutical Inc. Announces Acquisition of Assets from 40 JS LLC

2017-07-31T08:34:20+00:00

VANCOUVER, B.C., CANADA (February 17, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”) announces that it has successfully closed the previously described asset acquisition from 40J’s LLC and related entities. The Company paid $300,000 in cash at closing, issued 38,837,000 shares and unsecured 5 year notes in the principal [...]

M Pharmaceutical Inc. Announces Acquisition of Assets from 40 JS LLC 2017-07-31T08:34:20+00:00

SeeThruEquity Issues Update on M Pharmaceutical, Inc.

2017-07-31T08:38:11+00:00

NEW YORK, NY / ACCESSWIRE / February 16, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update note on M Pharmaceutical, Inc. (CSX: MQ; OTCQB: MPHMF). The report is available here: MQ February 2017 Update Note. M Pharmaceutical, Inc. ("M [...]

SeeThruEquity Issues Update on M Pharmaceutical, Inc. 2017-07-31T08:38:11+00:00

M Pharmaceutical Inc. Appoints Mr. Gary Thompson President & CEO

2017-07-31T08:39:19+00:00

VANCOUVER, B.C., CANADA (February 13, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), is announcing today that the company has appointed Mr. Gary Thompson of Fort Thomas, Kentucky to the serve as its President and CEO.  Mr. Thompson has served as the President and CEO of the company’s US [...]

M Pharmaceutical Inc. Appoints Mr. Gary Thompson President & CEO 2017-07-31T08:39:19+00:00

M Pharmaceutical Inc. Provides Strategic Report to Shareholders Highlighting Acquisitions and Product Development

2017-07-31T08:41:37+00:00

VANCOUVER, B.C., CANADA (February 10, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”) Mr. Gary Thompson, President and CEO of M Pharmaceutical USA Inc., has issued a comprehensive update letter to shareholders. Dear Shareholders of M Pharma: I am pleased to provide this update to shareholders regarding our growth [...]

M Pharmaceutical Inc. Provides Strategic Report to Shareholders Highlighting Acquisitions and Product Development 2017-07-31T08:41:37+00:00